DE60217129D1 - Chimärische nukleinsäuren kodierend für proteine, die effekte gegen viren induzieren - Google Patents
Chimärische nukleinsäuren kodierend für proteine, die effekte gegen viren induzierenInfo
- Publication number
- DE60217129D1 DE60217129D1 DE60217129T DE60217129T DE60217129D1 DE 60217129 D1 DE60217129 D1 DE 60217129D1 DE 60217129 T DE60217129 T DE 60217129T DE 60217129 T DE60217129 T DE 60217129T DE 60217129 D1 DE60217129 D1 DE 60217129D1
- Authority
- DE
- Germany
- Prior art keywords
- chimeric
- serotype
- nucleic acids
- viruses
- proteins
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 108090000623 proteins and genes Proteins 0.000 title abstract 5
- 102000004169 proteins and genes Human genes 0.000 title abstract 4
- 230000001939 inductive effect Effects 0.000 title abstract 2
- 102000039446 nucleic acids Human genes 0.000 title abstract 2
- 108020004707 nucleic acids Proteins 0.000 title abstract 2
- 150000007523 nucleic acids Chemical class 0.000 title abstract 2
- 241000700605 Viruses Species 0.000 title 1
- 241000725619 Dengue virus Species 0.000 abstract 2
- 230000000694 effects Effects 0.000 abstract 2
- 239000012634 fragment Substances 0.000 abstract 2
- 101710088194 Dehydrogenase Proteins 0.000 abstract 1
- 241000588650 Neisseria meningitidis Species 0.000 abstract 1
- 239000013604 expression vector Substances 0.000 abstract 1
- 102000037865 fusion proteins Human genes 0.000 abstract 1
- 108020001507 fusion proteins Proteins 0.000 abstract 1
- 230000028996 humoral immune response Effects 0.000 abstract 1
- 230000002766 immunoenhancing effect Effects 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 230000007170 pathology Effects 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
- 230000001681 protective effect Effects 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
- 230000003612 virological effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0006—Oxidoreductases (1.) acting on CH-OH groups as donors (1.1)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
- C12N2770/24122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Virology (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Microbiology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CU20010172A CU23245A1 (es) | 2001-07-16 | 2001-07-16 | CADENAS QUIMéRICAS CODIFICANTES PARA PROTEINAS INDUCTORAS DE EFECTOS CONTRA VIRUS. PREPARADOS UTILIZANDO PROTEINAS QUIMéRICAS |
| CU17201 | 2001-07-16 | ||
| PCT/CU2002/000006 WO2003008571A2 (es) | 2001-07-16 | 2002-07-12 | Cadenas quiméricas codificantes para proteínas inductoras de efectos contra virus |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DE60217129D1 true DE60217129D1 (de) | 2007-02-08 |
| DE60217129T2 DE60217129T2 (de) | 2007-10-31 |
Family
ID=40091633
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE60217129T Expired - Lifetime DE60217129T2 (de) | 2001-07-16 | 2002-07-12 | Chimärische nukleinsäuren kodierend für proteine, die effekte gegen viren induzieren |
Country Status (18)
| Country | Link |
|---|---|
| US (4) | US7279164B2 (de) |
| EP (1) | EP1418180B1 (de) |
| JP (1) | JP4417712B2 (de) |
| KR (1) | KR100991717B1 (de) |
| CN (1) | CN100378123C (de) |
| AT (1) | ATE349466T1 (de) |
| BR (1) | BR0211178A (de) |
| CA (1) | CA2453300C (de) |
| CU (1) | CU23245A1 (de) |
| DE (1) | DE60217129T2 (de) |
| DK (1) | DK1418180T3 (de) |
| ES (1) | ES2278041T3 (de) |
| GT (1) | GT200200150A (de) |
| MX (1) | MXPA04000486A (de) |
| MY (1) | MY138482A (de) |
| PT (1) | PT1418180E (de) |
| WO (1) | WO2003008571A2 (de) |
| ZA (1) | ZA200400289B (de) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CU23245A1 (es) * | 2001-07-16 | 2007-10-17 | Inst De Medicina Tropical Pedr | CADENAS QUIMéRICAS CODIFICANTES PARA PROTEINAS INDUCTORAS DE EFECTOS CONTRA VIRUS. PREPARADOS UTILIZANDO PROTEINAS QUIMéRICAS |
| CU23578A1 (es) * | 2005-09-16 | 2010-09-30 | Ct Ingenieria Genetica Biotech | Proteína de la cápsida del virus dengue inductora de respuesta protectora y composición vacunal |
| CU23586A1 (es) | 2005-11-22 | 2010-10-30 | Ct Ingenieria Genetica Biotech | Métodos y proteínas para el tratamiento profiláctico y/o terapéutico de los cuatro serotipos del virus de dengue y otros flavivirus |
| CU23630A1 (es) * | 2006-10-30 | 2011-02-24 | Ct Ingenieria Genetica Biotech | Moléculas peptídicas quiméricas con propiedades antivirales contra los virus de la familia flaviviridae |
| CU20080028A6 (es) | 2008-02-29 | 2011-02-24 | Ct Ingenieria Genetica Biotech | Compuestos químicos obtenidos in silico para la preparación de composiciones farmacéuticas para atenuar o inhibir la infección por virus dengue y otros flavivirus |
| SG10201508700XA (en) * | 2010-10-29 | 2015-11-27 | Merck Sharp & Dohme | Recombinant subunit dengue virus vaccine |
| CU24188B1 (es) * | 2012-12-27 | 2016-07-29 | Ct De Ingeniería Genética Y Biotecnología | Composición vacunal contra el virus dengue |
| ITRM20130458A1 (it) * | 2013-08-05 | 2015-02-05 | Internat Ct For Genetic En Gineering And | Vaccino genetico anti-dengue virus basato sugli ectodomini della proteina envelope |
| CN113583117B (zh) * | 2018-04-04 | 2022-04-15 | 中国科学院微生物研究所 | 一种高灵敏度的黄热病毒人源单克隆抗体及其应用 |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CU22302A1 (es) * | 1990-09-07 | 1995-01-31 | Cigb | Secuencia nucleotidica codificante para una proteina de la membrana externa de neisseria meningitidis y uso de dicha proteina en preparados vacunales |
| EP1605047B1 (de) | 1991-09-19 | 2009-09-16 | The United States of America, as represented by the Secretary Department of Health and Human Services | Chimäre und/oder wachstumgehemmte Flaviviren |
| ES2184869T3 (es) * | 1995-05-24 | 2003-04-16 | Hawaii Biotech Group | Vacuna sub-unitaria contra la infeccion por flavivirus. |
| CU22559A1 (es) | 1996-01-17 | 1999-05-03 | Ct Ingenieria Genetica Biotech | Sistema de expresión de antígenos heterologos en e. coli como proteínas de fusión |
| WO1997043310A1 (en) | 1996-05-10 | 1997-11-20 | Schering Corporation | Synthetic inhibitors of hepatitis c virus ns3 protease |
| CU22666A1 (es) | 1996-11-25 | 2001-04-27 | Inst De Medicina Tropical Pedro Kouri | Procedimiento para la expresión de genes de los virus del dengue en la levadura pichia pastoris, adns recombinantes y microorganismos transformados |
| CU22683A1 (es) * | 1997-01-15 | 2001-07-20 | Inst De Medicina Tropical Pedro Kouri | Epítopes de la proteína pre-m/m del virus del dengue, péptidos sintéticos, proteínas quiméricas y sus usos |
| HUP0004853A3 (en) | 1997-08-11 | 2001-12-28 | Boehringer Ingelheim Ca Ltd | Hepatitis c inhibitor peptides, process for preparation thereof, pharmaceutical compositions comprising thereof, their use and their intermediates |
| ATE314476T1 (de) | 1997-10-08 | 2006-01-15 | Us Gov Health & Human Serv | Chimärer impfstoff gegen das zeckenenzephalitis virus |
| BR0010361A (pt) | 1999-04-30 | 2003-06-10 | Chiron Corp | Seq ências genÈmicas de neisseria e uso destas |
| CU23245A1 (es) | 2001-07-16 | 2007-10-17 | Inst De Medicina Tropical Pedr | CADENAS QUIMéRICAS CODIFICANTES PARA PROTEINAS INDUCTORAS DE EFECTOS CONTRA VIRUS. PREPARADOS UTILIZANDO PROTEINAS QUIMéRICAS |
| AU2003239932A1 (en) * | 2002-05-31 | 2003-12-19 | Acambis, Inc. | Tetravalent dengue vaccines |
| US20040213808A1 (en) | 2002-12-11 | 2004-10-28 | Michael Lieberman | Recombinant vaccine against flavivirus infection |
| EP1454988A1 (de) | 2003-03-03 | 2004-09-08 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | Infektiöse Flavivirus Pseudo-Partikel, welche funktionelle prM-E Hüllproteine enthalten |
| WO2005002501A2 (en) | 2003-04-22 | 2005-01-13 | Children's Medical Center Corporation | Novel druggable regions in the dengue virus envelope glycoprotein and methods of using the same |
| EP1841785A2 (de) | 2005-01-19 | 2007-10-10 | Vaxinnate Corporation | Zusammensetzungen, die pathogen-assoziierte molekulare muster und antigene enthalten und deren verwendung zur stimulation des immunsystems |
| CA2508266A1 (fr) | 2005-06-20 | 2006-12-20 | Institut Pasteur | Polypeptides chimeriques et leurs applications therapeutiques contre une infection a flaviviridae |
| CU23632A1 (es) | 2006-04-28 | 2011-02-24 | Ct Ingenieria Genetica Biotech | Métodos para la identificación de candidatos terapéuticos contra enfermedades causadas por flavivirus y moléculas antivirales. |
-
2001
- 2001-07-16 CU CU20010172A patent/CU23245A1/es unknown
-
2002
- 2002-07-10 MY MYPI20022623A patent/MY138482A/en unknown
- 2002-07-12 US US10/484,114 patent/US7279164B2/en not_active Expired - Fee Related
- 2002-07-12 DK DK02760073T patent/DK1418180T3/da active
- 2002-07-12 WO PCT/CU2002/000006 patent/WO2003008571A2/es active IP Right Grant
- 2002-07-12 KR KR1020047000610A patent/KR100991717B1/ko not_active IP Right Cessation
- 2002-07-12 EP EP02760073A patent/EP1418180B1/de not_active Expired - Lifetime
- 2002-07-12 PT PT02760073T patent/PT1418180E/pt unknown
- 2002-07-12 CN CNB028143507A patent/CN100378123C/zh not_active Expired - Fee Related
- 2002-07-12 GT GT200200150A patent/GT200200150A/es unknown
- 2002-07-12 JP JP2003514888A patent/JP4417712B2/ja not_active Expired - Fee Related
- 2002-07-12 ES ES02760073T patent/ES2278041T3/es not_active Expired - Lifetime
- 2002-07-12 AT AT02760073T patent/ATE349466T1/de not_active IP Right Cessation
- 2002-07-12 BR BR0211178-0A patent/BR0211178A/pt not_active IP Right Cessation
- 2002-07-12 MX MXPA04000486A patent/MXPA04000486A/es active IP Right Grant
- 2002-07-12 DE DE60217129T patent/DE60217129T2/de not_active Expired - Lifetime
- 2002-07-12 CA CA2453300A patent/CA2453300C/en not_active Expired - Fee Related
-
2004
- 2004-01-14 ZA ZA200400289A patent/ZA200400289B/xx unknown
-
2007
- 2007-02-13 US US11/705,696 patent/US7566457B2/en not_active Expired - Fee Related
-
2009
- 2009-06-12 US US12/483,607 patent/US7947281B2/en not_active Expired - Fee Related
-
2011
- 2011-04-26 US US13/094,287 patent/US8105606B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| DK1418180T3 (da) | 2007-05-07 |
| US7947281B2 (en) | 2011-05-24 |
| KR20040030056A (ko) | 2004-04-08 |
| KR100991717B1 (ko) | 2010-11-03 |
| US8105606B2 (en) | 2012-01-31 |
| CN100378123C (zh) | 2008-04-02 |
| US7279164B2 (en) | 2007-10-09 |
| ZA200400289B (en) | 2004-09-12 |
| US7566457B2 (en) | 2009-07-28 |
| US20090274718A1 (en) | 2009-11-05 |
| GT200200150A (es) | 2003-06-19 |
| CA2453300C (en) | 2012-03-20 |
| CN1531548A (zh) | 2004-09-22 |
| WO2003008571A3 (es) | 2004-03-04 |
| JP4417712B2 (ja) | 2010-02-17 |
| DE60217129T2 (de) | 2007-10-31 |
| ES2278041T3 (es) | 2007-08-01 |
| US20040234951A1 (en) | 2004-11-25 |
| ATE349466T1 (de) | 2007-01-15 |
| WO2003008571A2 (es) | 2003-01-30 |
| MXPA04000486A (es) | 2005-03-07 |
| WO2003008571A9 (es) | 2004-04-15 |
| BR0211178A (pt) | 2004-08-10 |
| EP1418180A2 (de) | 2004-05-12 |
| EP1418180B1 (de) | 2006-12-27 |
| CU23245A1 (es) | 2007-10-17 |
| JP2004537306A (ja) | 2004-12-16 |
| MY138482A (en) | 2009-06-30 |
| CA2453300A1 (en) | 2003-01-30 |
| US20070141081A1 (en) | 2007-06-21 |
| US20110200628A1 (en) | 2011-08-18 |
| PT1418180E (pt) | 2007-04-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20180000912A1 (en) | Virus Vectors Expressing Multiple Epitopes of Tumor Associated Antigens For Inducing Antitumor Immunity | |
| Alexander et al. | A decaepitope polypeptide primes for multiple CD8+ IFN-γ and Th lymphocyte responses: evaluation of multiepitope polypeptides as a mode for vaccine delivery | |
| ATE219948T1 (de) | Rekombinante impfstoffe die immunogene attenuierte rpos-positiv phentotyp bakterien enthalten | |
| EP1363660A4 (de) | "überlegene molekulare vakzine auf basis selbstreplizierender rna, suizid-dna oder nacktem dna-vektor, zur verknüpfung von antigen mit polypeptid zur förderung der antigenpräsentation" | |
| DE60234375D1 (de) | VERPACKUNG VON IMMUNSTIMULIERENDEM CpG IN VIRUSÄHNLICHEN PARTIKELN: HERSTELLUNGSVERFAHREN UND VERWENDUNG | |
| WO2003048184A3 (en) | Flavivirus ns1 subunit vaccine | |
| MXPA05009289A (es) | Conjugados de particulas tipo virus del analogo del peptido melan-a. | |
| CY1111167T1 (el) | Χιμαιρικοι λοιμωδεις κλωνοι dna του κυκλοϊου των χοιρων και χρησεις εξ αυτων | |
| BR9712852A (pt) | Plasmìdeo, composição, processo de imunização de um indivìduo contra um patógeno, vacina recombinante, patógeno vivo atenuado, proteìna bl-1 substancialmente pura, vetor recombinante de expressão, e, anticorpo isolado | |
| WO2007149715A3 (en) | Novel dna sequences, vectors and proteins of avian influenza hemagglutinin | |
| DE60217129D1 (de) | Chimärische nukleinsäuren kodierend für proteine, die effekte gegen viren induzieren | |
| NO20110429L (no) | Polypeptider og nukleinsyre-DNA for anvendelse innen medisin | |
| BR112020013974A2 (pt) | Formulação para administração de rna | |
| WO2005081716A3 (en) | DNA VACCINES TARGETING ANTIGENS OF THE SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS (SARS-CoV) | |
| DK0831899T3 (da) | Rekombinant koppevirus-calicivirus-præparater og anvendelser | |
| JP2011120598A (ja) | Ｈｌａ結合性ペプチド、それをコードするｄｎａ断片および組み換えベクター | |
| DE60234475D1 (de) | Rekombinante hybrid-allergenkonstrukte mit verringerter allergenität unter beibehaltung der immunogenität des natürlichen allergens | |
| ZA200602107B (en) | Piroplasmid vaccine | |
| PT778894E (pt) | Vacina da peritonite infecciosa felina. | |
| EP1281758A3 (de) | Vier menschliche Zinc-Finger Proteine: MDZ3, MDZ4, MDZ7 und MDZ12 | |
| HUP0103871A2 (hu) | Rekombináns CELO-vírus és CELO vírus DNS | |
| DE69533167D1 (de) | Impfstoffe gegen den hepatitis b und c virus | |
| DE60035680D1 (de) | Komplette gensequenz des esel-leukozyten-impfstoffstammes des equinen infektiösen anemievirus und ihre anwendung | |
| TH76653A (th) | สายไคเมอริค ซึ่งเป็นรหัสสำหรับโปรตีนซึ่งเหนี่ยวนำผลต่อไวรัส | |
| DE60125569D1 (de) | 13245, eine neue, humane protein kinase vom typ myotonische dystrophie protein kinase und anwendungen davon |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8364 | No opposition during term of opposition |